Fertility Focus, Inc. Develops product for use in cattle production. Our Product EmGarde increases fertility in the Embryo Transfer Process up to 20%.

1. Fertility Focus
Enhancing the nation’s herd

2. Multiple
Ovulation
Embryo
Transfer
500,000 embryos transferred world-wide
249,000 in North America
53,000 donor cows

3. The Problem
58% pregnancy rate
Prostaglandin
(PGF2alpha)

4. Binding retards
development
Uterus
PGF2α

5. The Solution:
2 ml 1 ltr+
US Patent # 7,075,197
Canada # 2,594,358

6. PGF Receptor
Antagonist
PGF2α
Uterus

7. The Value Proposition
15% increased fertility
• Up to 50 pregnancies
per donor per year
• $75,000 value

8. The Market
Worldwide - $168 million
N. America - $78.9 million
Total IVF and MOET available market

9. Market Strategy
Distributors
Personal Networks
Trade Shows and Conferences:
• National Cattlemen’s Beef Association
• American Embryo Transfer Association
Website

10. Timeline
2013 2014 2015
Company
Formed
License
Agreement
Business
Model
Initial
Production
Angel
Round
$150k
SBIR
proposal
$1m
Revenue
Release
Lyophilized
Product
Release
IVF
Product
$1.8m
Revenue

11. Validations
• License Agreement with UTRF
• Facility Use Agreement with UTAI
• Co-Founded with Tech 20/20
• Initial Product Introduction
• Inventors/researchers on Team

12. The Team
Neal Schrick, PhD – Chairman
• Dean UT Animal Sciences
Lannett Edwards, PhD – CTO
• Lead researcher on cloning
Shawn Carson, MBA – President
• Tech 20/20
David Snider, CPA – CFO
• Tech20/20

13. Shawn Carson
carson@tech2020.org
865.773.8974
Enhancing the nation’s herd